background image

Esophageal Cancer Clinical Trials

Find clinical trials for esophageal cancer. Search for esophageal cancer clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

for
Esophageal Adenocarcinoma, Esophageal Cancer,
Location: 1 recruiting location
Sponsor: Brown University

Sex: All

Age: 18+

Code: NCT05480384

Phase2, Recruiting
Active & Responsive

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

for
Brain Cancer, Breast Cancer, Bladder Cancer, Cervical Cancer,
Location: 14 recruiting locations
Sponsor: Adela, Inc

Sex: All

Age: 40+

Code: NCT05366881

Recruiting
Active & Responsive

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

for
Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer,
Location: 1 recruiting location
Sponsor: Lumicell, Inc.

Sex: All

Age: 18+

Code: NCT02584244

Phase1, Phase2, Recruiting
Active & Responsive

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

for
Gastric Cancer, Gastroesophageal-junction Cancer,
Location: 8 recruiting locations
Sponsor: Legend Biotech USA Inc

Sex: All

Age: 18 - 70+

Code: NCT05539430

Phase1, Recruiting
Active & Responsive

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

for
Gastric Cancer, Esophageal Cancer, Stomach Cancer,
Location: 1 recruiting location
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT05187182

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: 14 recruiting locations
Sponsor: VM Oncology, LLC

Sex: All

Age: 18 - 70+

Code: NCT03556228

Phase1, Recruiting
Active & Responsive

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

for
Barrett's Esophagus, Esophageal Neoplasm
Location: 8 recruiting locations
Sponsor: Case Western Reserve University

Sex: All

Age: 18+

Code: NCT00288119

Recruiting
Active & Responsive

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

for
Esophageal Squamous Cell Carcinoma
Location: 4 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05319730

Phase1, Phase2, Recruiting
Active & Responsive

Study of XB010 in Subjects With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors,
Location: 11 recruiting locations
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06545331

Phase1, Recruiting
Active & Responsive

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: 13 recruiting locations
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase1, Phase2, Recruiting